Davide Zocco

Davide Zocco currently serves as the Head of Exosomes Development and Site Head at Lonza, a position held since September 2020. Prior to this role, Davide Zocco was the Chief Technology Officer at Exosomics from July 2013 to November 2021, where responsibilities included developing standard operating procedures for sample collection and analysis, as well as managing collaborations in companion and molecular diagnostics. Davide Zocco's early career featured a Postdoctoral Research Fellowship at Harvard University, focusing on the effects of small-molecule inhibitors in inflammatory arthritis, and a PhD Research Associate role at University College Dublin, supervising postgraduate students and publishing research. Educational background includes a PhD in Molecular Immunology and a Master's degree in Industrial Biotechnology, as well as postdoctoral studies at Harvard University.